本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Xtl生物制药

1.18
+0.00500.43%
成交量:2,074.00
成交额:2,442.20
市值:1,035.63万
市盈率:-3.92
高:1.22
开:1.22
低:1.17
收:1.17
52周最高:2.50
52周最低:0.8600
股本:881.39万
流通股本:451.89万
量比:0.52
换手率:0.05%
股息:- -
股息率:- -
每股收益(TTM):-0.2999
每股收益(LYR):-0.1525
净资产收益率:-26.83%
总资产收益率:-24.74%
市净率:1.91
市盈率(LYR):-7.70

数据加载中...

2025/05/01

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/04/30

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/03/22

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/03/30

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/05/19

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/15

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/11/25

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/12

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/01/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/22

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/13

非美公司披露报告

[Amend] Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/31

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]